Bain Capital Life Sciences Investors, LLC Q1 2024 Filing
Filed May 15, 2024
Portfolio Value
$1.2T
Holdings
26
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (26 positions)
| Stock | Value |
|---|---|
NAMSNEWAMSTERDAM PHARMA COMPANY | $247.7B |
NUVLNUVALENT INC | $202.5B |
DNTHDIANTHUS THERAPEUTICS INC | $89.8B |
IRONDISC MEDICINE INC | $82.0B |
KYTXKYVERNA THERAPEUTICS INC | $78.6B |
PHVSPHARVARIS N V | $76.3B |
YB4PSAVARA INC | $72.5B |
ANNXANNEXON INC | $62.4B |
SLDBSOLID BIOSCIENCES INC | $53.7B |
MDGLMADRIGAL PHARMACEUTICALS INC | $52.6B |
—MERSANA THERAPEUTICS INC | $38.8B |
CABACABALETTA BIO INC | $27.6B |
ASNSUSDX4 PHARMACEUTICALS INC | $23.5B |
TNGXTANGO THERAPEUTICS INC | $23.0B |
ARQTARCUTIS BIOTHERAPEUTICS INC | $19.9B |
NRIXNURIX THERAPEUTICS INC | $16.6B |
SYRSSYROS PHARMACEUTICALS INC | $14.7B |
MRNS*MARINUS PHARMACEUTICALS INC | $12.6B |
AVIRATEA PHARMACEUTICALS INC | $10.0B |
CCCCC4 THERAPEUTICS INC | $9.3B |
RPIDRAPID MICRO BIOSYSTEMS INC | $8.2B |
IVVDINVIVYD INC | $8.0B |
NAUTNAUTILUS BIOTECHNOLOGY INC | $5.9B |
ACRSACLARIS THERAPEUTICS INC | $3.7B |
XLOXILIO THERAPEUTICS INC | $3.0B |
NAMSNEWAMSTERDAM PHARMA COMPANY | $1.1B |